Abstract 1901: Disitamab Vedotin, a Clinical Stage HER2-directed Antibody-Drug Conjugate, Shows Potent Antitumor Activity As a Monotherapy in Preclinical Urothelial Cancer Models
Cancer Research(2024)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要